chr3-50364728-G-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 3P and 5B. PM2PP2BP4_StrongBS1_Supporting
The ENST00000424201.7(CACNA2D2):c.3370C>T(p.Leu1124Phe) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00112 in 1,556,012 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★). Synonymous variant affecting the same amino acid position (i.e. L1124L) has been classified as Likely benign.
Frequency
Consequence
ENST00000424201.7 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CACNA2D2 | NM_006030.4 | c.3370C>T | p.Leu1124Phe | missense_variant | 38/38 | ENST00000424201.7 | NP_006021.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CACNA2D2 | ENST00000424201.7 | c.3370C>T | p.Leu1124Phe | missense_variant | 38/38 | 1 | NM_006030.4 | ENSP00000390329.2 | ||
CACNA2D2 | ENST00000423994.6 | c.3400C>T | p.Leu1134Phe | missense_variant | 39/39 | 5 | ENSP00000407393.2 | |||
CACNA2D2 | ENST00000266039.7 | c.3376C>T | p.Leu1126Phe | missense_variant | 38/38 | 1 | ENSP00000266039.3 | |||
CACNA2D2 | ENST00000360963.7 | c.3169C>T | p.Leu1057Phe | missense_variant | 38/38 | 1 | ENSP00000354228.3 | |||
ENSG00000272104 | ENST00000606589.1 | c.128-1569G>A | intron_variant | 3 | ENSP00000476225.1 |
Frequencies
GnomAD3 genomes AF: 0.000841 AC: 128AN: 152216Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.000656 AC: 108AN: 164638Hom.: 0 AF XY: 0.000648 AC XY: 57AN XY: 88000
GnomAD4 exome AF: 0.00115 AC: 1608AN: 1403796Hom.: 0 Cov.: 33 AF XY: 0.00109 AC XY: 758AN XY: 693420
GnomAD4 genome AF: 0.000841 AC: 128AN: 152216Hom.: 0 Cov.: 33 AF XY: 0.000672 AC XY: 50AN XY: 74368
ClinVar
Submissions by phenotype
not provided Uncertain:2
Uncertain significance, criteria provided, single submitter | clinical testing | GeneDx | May 08, 2024 | In silico analysis indicates that this missense variant does not alter protein structure/function; Has not been previously published as pathogenic or benign to our knowledge - |
Uncertain significance, criteria provided, single submitter | clinical testing | Mayo Clinic Laboratories, Mayo Clinic | Dec 22, 2022 | BP4 - |
Early infantile epileptic encephalopathy with suppression bursts Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Nov 01, 2022 | This sequence change replaces leucine, which is neutral and non-polar, with phenylalanine, which is neutral and non-polar, at codon 1124 of the CACNA2D2 protein (p.Leu1124Phe). This variant is present in population databases (rs147278705, gnomAD 0.1%), and has an allele count higher than expected for a pathogenic variant. This variant has not been reported in the literature in individuals affected with CACNA2D2-related conditions. ClinVar contains an entry for this variant (Variation ID: 461320). Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Tolerated"; PolyPhen-2: "Possibly Damaging"; Align-GVGD: "Class C0"). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at